🚨 Last chance to submit your abstract for #ESCMIDGlobal2027!
⏰ Today is the final day! Submissions close at 17:00 CET, with no further extensions.
Don't miss your chance to be part of the scientific programme!
👉 escmid.org/congress-events/e…
Join this onsite course in February 2027 exploring clinical trial design, regulatory requirements and the evidence needed to bring phage therapy into clinical practice.
👉 Learn more and register today: ow.ly/zkqu5107iuH
The #AMR ecosystem brings together stakeholders from all different viewpoints to work at speed to solve the problems at hand. Thank you to everyone in this unique ecosystem who keep innovation moving to combat #AntimicrobialResistance.
#WAAW2026 #OneHealth #GAMRIC2026
ESCMID retweeted
🥳 Happy antibiotic awareness week. This observance is a great time for everyone to take a moment and help raise awareness for the threat of antibiotic resistance and how precious antibiotics are to human health. #USAAW #AntibioticAwarenessWeek #SaveABX #AMRawareness
📢 Good news! The #ESCMIDGlobal2027 abstract submission deadline has been extended!
⏰ The final deadline is Friday, 20 November, at 17:00 CET. No further extensions!
Don't miss your last chance to submit your research!
👉 ow.ly/L6AF5107f4F
Now is the time to act!
World AMR Awareness Week begins today under the theme One Health, one action: Prevent AMR now!
Watch the #AMR webinar series, listen to our #WAAW podcast episode and get information on going blue to fight #AntimicrobialResistance: ow.ly/3BNm5107kw9
🚨 New Epi Alert this week: Ebola in the DRC, diphtheria in Nigeria and HIV in Russia remain major concerns. Mexico reports rising rickettsiosis cases, the US faces measles challenges, and Qatar and Switzerland report MERS and chikungunya cases. ow.ly/9HJm50Y3Qs0
📝 Strengthen your skills in research design, proposal development and scientific writing! Join this online course to learn how to develop research questions, choose appropriate methodologies and navigate the publication process.
Learn more and register: ow.ly/m1k05106uYK
💡 Join us on Wednesday, 25 November at 12:00 CET for a webinar on the Bundibugyo virus disease outbreak in the DRC, six months on.
Explore updates on outbreak response, clinical care, research and ethical challenges.
🔗 Register today: ow.ly/lzmF5106YOT
☀️ The preliminary programme for ESCMID Summer School 2027 is now online! Apply for an attendance grant by 30 November 2026.
Registration opens on 04 January 2027. See you in Zagreb in June!
🔗 ow.ly/Xwio5106n60
ESCMID retweeted
Malaria remains a leading cause of morbidity and mortality globally, particularly in sub-Saharan Africa. This narrative review aims to highlight the emerging role of monoclonal antibody interventions for malaria prevention:
clinicalmicrobiologyandinfec…
⏰ The #ESCMIDGlobal2027 abstract submission deadline is 18 November! Don't miss your chance – an extension is not guaranteed.
Submit your abstract: ow.ly/jO8G5106nV3
Explore travel grants and awards: ow.ly/T3QR5106nZO
🔬 The Mobile Lab returns to ESCMID Global 2027!
Advance your laboratory skills with expert-led workshops in fungal diagnostics, anaerobic bacteriology & parasitology, designed for all experience levels.
🧫 Sign up when registering for the congress!
🔗 ow.ly/baM25104q9K
📢 Applications are open for the 2027 ESCMID CAREer Grant!
Supporting members balancing research and family-care responsibilities through funding for qualified support personnel.
📅 Apply by 13 January 2027!
🔗 ow.ly/y79I5104qnI
11
1,314
🚨 New Epi Alert this week: Arbovirus activity remains high, measles cases surge in the US, and drug-resistant typhoid is rising in France. Meanwhile, West Nile virus transmission declines in Europe, and mpox persists in Thailand.
🔗ow.ly/9HJm50Y3Qs0
Build your knowledge of classical and emerging hepatitis viruses, from hepatitis A–E to viral haemorrhagic fevers including yellow fever, dengue & Crimean-Congo haemorrhagic fever.
A must for those interested in viral liver diseases.
Register today: ow.ly/qtiq50ZGvGG
ESCMID retweeted
An original article on persistent and pathogen-specific infection risk during long-term survivorship after CD19 chimeric antigen receptor T-cell therapy: clinicalmicrobiologyandinfec…



















